| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on December 3, 2003
From the Stroke Clinic (C.C., F.B.) and the Departments of Genetics (E.A., A.J., L.M.), Neurochemistry (C.R.), and Radioimmunoassay (M.d.l.A.F., I.G.), Instituto Nacional de Neurología y Neurocirugía "Manuel Velasco Suárez," Mexico C.C. is now appointed at the Stroke Clinic, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City. F.B. has moved to Hospital Angeles, Querétaro, Mexico. * To whom correspondence should be addressed. E-mail: carloscantu_brito{at}hotmail.com.
Background--Elevated plasma levels of homocysteine are associated with an increased risk of deep-vein thrombosis. Through a case-control study, we examined the potential association among homocysteine, folate and vitamin B12 levels, and the common C677 Methods--Forty-five patients with CVT and 90 control subjects were studied. Plasma levels of homocysteine (fasting and after methionine load), folate, and vitamin B12 were measured. Genotyping of the MTHFR gene was also performed. The estimated risk of CVT associated with hyperhomocysteinemia, low vitamin levels, and MTHFR mutation were expressed as odds ratio (OR) and its 95% CI (crude and after adjusting by other independent variables). Results--The adjusted OR for CVT associated with high (>90th percentile) fasting levels of homocysteine was 4.6 (1.6 to 12.8). The association between low plasma folate values (<10th percentile) and presence of CVT was 3.5 (1.2 to 10.0) after adjustment for confounding factors. There was a higher frequency of MTHFR mutation in patients with CVT (22% versus 10%), but it was not statistically significant (P=0.098). Patients with MTHFR mutation and low folate levels presented the highest homocysteine levels. Conclusions--High plasma concentrations of homocysteine and low plasma folate levels were associated with an increased risk of CVT in this population in which low socioeconomic conditions and deficient nutritional status may contribute to its relatively high incidence.
Revised on April 16, 2004
Accepted on April 21, 2004
Hyperhomocysteinemia, Low Folate and Vitamin B12 Concentrations, and Methylene Tetrahydrofolate Reductase Mutation in Cerebral Venous Thrombosis
Carlos Cantu MD, MSc*;
T mutation in the methylene tetrahydrofolate reductase (MTHFR) gene in patients with cerebral venous thrombosis (CVT).
This article has been cited by other articles:
![]() |
C. L. Wong MD, H. G.C. Van Spall MD, K. A. Hassan MB, J. Coret-Simon MD, D. J. Sahlas MD, and S. L. Shumak MD A young man with deep vein thrombosis, hyperhomocysteinemia and cobalamin deficiency Can. Med. Assoc. J., January 29, 2008; 178(3): 279 - 281. [Full Text] [PDF] |
||||
![]() |
F. Dentali, M. Crowther, and W. Ageno Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis Blood, April 1, 2006; 107(7): 2766 - 2773. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Stam Thrombosis of the Cerebral Veins and Sinuses N. Engl. J. Med., April 28, 2005; 352(17): 1791 - 1798. [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |